Search results for "Toxic"

showing 10 items of 6968 documents

Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma

2011

Objective  The aim of this study was to evaluate the safety and efficacy profile of pegylated interferon α-2b (PEG-IFN α-2b) in combination with photochemotherapy (PUVA) in the treatment of cutaneous T-cell lymphoma (CTCL) in comparison with standard IFN α plus PUVA. Design  Retrospective cohort study over a period of 7 years. Patients and interventions  A total of 17 consecutive CTCL patients (stage IA–IV) were retrospectively analysed for toxicity and response rates associated with PEG-IFN α-2b (1.5 μg/kg weekly) plus PUVA (n = 9) or standard IFN α-2a (9 MIU 3×/week) plus PUVA (n = 8). Main outcome measures  Differences of response rates (complete/partial remission), progression-free surv…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentCutaneous T-cell lymphomaDermatologymedicine.diseaseDermatologyGastroenterologyDiscontinuationchemistry.chemical_compoundInfectious DiseaseschemistryPegylated interferonInternal medicinePUVA therapyToxicitymedicinebusinessProspective cohort studyAdverse effectPsoralenmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Serum isoniazid concentration in the patients as an indicator of the effectiveness and toxicity of tuberculosis treatment

2019

Introduction The low serum concentration of the anti-tuberculosis (TB) drugs in TB patients is observed quite often, but the significance of this phenomenon remains controversial. Aim The aim of the presented research was to clarify the association between isoniazid concentration and TB-treatment outcomes. Material and methods Blood samples were obtained from 86 patients with newly diagnosed pulmonary TB at Odessa Regional TB Hospital in 2015. The level of isoniazid in blood was measured 2 h, 4 h, 6 h, and 24 h after the administration of isoniazid. The medical records of the enrolled patients at the beginning and at the end of the in-patient treatment, and the activity of the biochemical i…

medicine.medical_specialtyconcentrationisoniazidTuberculosistreatmentbusiness.industryIsoniazidtoxicityGeneral Medicinemedicine.diseaseGastroenterologytuberculosisInternal medicineToxicitymedicinebusinessmedicine.drugPolish Annals of Medicine -Rocznik Medyczny
researchProduct

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective …

2018

Abstract Background: Triplet-based lenalidomide plus dexamethasone (Rd) combinations have become the new standard of care for early relapse and refractory multiple myeloma (RRMM). Carfilzomib is a novel selective proteasome inhibitor (PI) with high efficacy in RRMM. The ASPIRE phase 3 trial showed the superiority of carfilzomib-based triplet (KRd compared to Rd), leading to approval of K for RRMM. However, little is known about safety and efficacy of KRd outside a clinical trial context. Experimental design and aims: In 11 Sicilian Centers belonging to the Sicilian Myeloma Network, from November 2016, when KRd regimen was approved in Italy, to June 2018, 103 consecutive RRMM patients (previ…

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiescomplete remissionImmunologylenalidomideadverse eventContext (language use)dexamethasoneBiochemistrychemistry.chemical_compoundMedian follow-upInternal medicinemedicinecarfilzomib dexamethasone lenalidomide multiple myeloma toxic effect adverse event bortezomib complete remission erythropoietin febrile neutropeniaMultiple myelomaLenalidomidetoxic effectcarfilzomibbusiness.industryCumulative dosebortezomibCell BiologyHematologymedicine.diseaseCarfilzomibmultiple myelomaRegimenfebrile neutropeniachemistryerythropoietinbusinessFebrile neutropeniamedicine.drug
researchProduct

Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice

2018

Bernd Tischer,1 Renato Marino,2 Mariasanta Napolitano3 1Kantar Health, Munich, Germany; 2Haemophilia and Thrombosis Centre, University Hospital of Bari, Apulia, Italy; 3University of Palermo, Reference Regional Center for Thrombosis and Hemostasis Hematology Unit, Palermo, Italy Objectives: To gain insights into the usage of factor VIII (FVIII) products by patients diagnosed with moderate/severe hemophilia A, and to assess the impact and perceived importance of product storage.Methods: In this study, 200 patients diagnosed with moderate or severe hemophilia A across seven countries participated. Data were collected via a 30-minute, face-to-face interview in six countries and via a web-based…

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitieshemophilia A recombinant FVIII plasma-derived FVIII storage reconstitution stabilityTreatment Adherence haemophiliaActivities of daily livingMedicine (miscellaneous)030204 cardiovascular system & hematologySevere hemophilia AHaemophiliaHemophilia Astorage03 medical and health sciences0302 clinical medicinePatient satisfactionrecombinant FVIIIplasma-derived FVIIIhemic and lymphatic diseasesMedicine030212 general & internal medicineProduct (category theory)Pharmacology Toxicology and Pharmaceutics (miscellaneous)Original Researchlcsh:R5-920business.industryHealth Policystabilitymedicine.diseasePatient preferenceConjoint analysisProduct choicePatient Preference and AdherenceEmergency medicinereconstitutionbusinesslcsh:Medicine (General)Social Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

An unusual fatal case of overdose of Vinblastine and review of literature

2017

The pharmacological treatment of neoplasia is based on the use of chemotherapeutic substances. Chemotherapeutic agents can cause acute and chronic toxicity even at therapeutic doses. For this reason their overdose puts a patient’s life at severe risk. This work presents an unusual fatal case of overdose subsequent to an accidental massive administration of Vinblastine (90 mg instead of 9 mg), slow bolus (five minutes), to a 33-year-old woman who suffered from Hodgkin’s Lymphoma. The administration of the massive dose was due to a transcription error of the therapeutic treatment plan and miscommunication between the health professionals which caused the use of the wrong dose. The foren…

medicine.medical_specialtydeath; intoxication; medical malpractice; overdose; Vinblastine; 2734Therapeutic treatment2734Poison controlmedical malpracticeVinblastinePathology and Forensic MedicinePharmacological treatment03 medical and health sciences0302 clinical medicineBolus (medicine)intoxicationdeathmedicine030216 legal & forensic medicineIntensive care medicineChronic toxicitybusiness.industrymedicine.diseaseLymphomaVinblastineSurgery030220 oncology & carcinogenesisAccidentaloverdosebusinessmedicine.drug
researchProduct

Wellbeing and occupational risk perception among health care workers: a multicenter study in Morocco and France

2016

International audience; BACKGROUND: The study analyzes health care workers' (HCWs) occupational risk perception and compares exposure to occupational risk factors in Moroccan and French hospitals.METHOD: Across nine public hospitals from three Moroccan regions (north, center and south), a 49 item French questionnaire, based on the Job Content Questionnaire, and 4 occupational risks subscales, was distributed to 4746 HCWs. Internal consistency of the study was determined for each subscale. Confirmatory factor analysis was conducted on the Moroccan questionnaire. Psychosocial job demand, job decision latitude and social support scores analysis was used to isolate high strain jobs. Occupationa…

medicine.medical_specialtyeducationPoison control[SHS.PSY]Humanities and Social Sciences/PsychologyToxicologyOccupational safety and health03 medical and health sciencesSocial support0302 clinical medicineEnvironmental healthHealth careMedicine030212 general & internal medicineMedication usebusiness.industryPublic healthResearchPublic Health Environmental and Occupational HealthPublic hospitalOccupational stressRisk exposure030210 environmental & occupational healthHigh strain3. Good healthPublic hospitalOccupational stressbusinessPsychosocialSafety ResearchJournal of Occupational Medicine and Toxicology
researchProduct

The evolution of European Medicines Agency drug approval: the adaptive licensing: Table 1

2015

In March 2014, the European Medicines Agency (EMA) launched a pilot project of ‘adaptive licensing’ to speed up access to drugs in development, in order to respond to unmet medical needs. The project will involve parallel scientific advice from the regulatory agency, pharmaceutical industry, the companies Health Technology Assessment (HTAs) bodies, organisations studying guidelines on clinical treatment and patient associations. The traditional process of drug authorisation is divided into several parts, involving in vitro studies and in vivo studies in animals (preclinical studies), as well as phase 1–3 randomised controlled trials conducted in humans over a predefined period. When authori…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationHealth technology030226 pharmacology & pharmacyClinical pharmacyTransplantation03 medical and health sciences0302 clinical medicineNursing030220 oncology & carcinogenesisFamily medicinePharmacovigilanceMedicineObservational studyGeneral Pharmacology Toxicology and PharmaceuticsbusinesseducationAdverse effectPharmaceutical industryEuropean Journal of Hospital Pharmacy
researchProduct

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve i…

2018

Elevated carbohydrate antigen 125 (CA125) predicts adverse outcome after transcatheter aortic valve implantation (TAVI). While known underlying pathophysiological mechanisms of elevated CA125 include serosal effusions and inflammatory stimuli, clinical determinants associated with elevated CA125 in patients referred for TAVI remain unknown. Therefore, we investigated clinical, laboratory and echocardiographic determinants of elevated CA125 in patients with severe aortic valve stenosis referred for TAVI.This study includes 650 patients with severe aortic stenosis referred for TAVI. Baseline CA125 was determined by an immunoassay and dichotomized (elevated versus normal) based on the manufact…

medicine.medical_specialtyendocrine system diseasesTranscatheter aorticAdverse outcomesHealth Toxicology and MutagenesisClinical Biochemistry030204 cardiovascular system & hematologyRisk AssessmentBiochemistryVentricular Function LeftNyha classTranscatheter Aortic Valve ReplacementHemoglobins03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineHumansMedicineIn patient030212 general & internal medicineAgedAged 80 and overbusiness.industryAortic Valve Stenosismedicine.diseaseTricuspid Valve Insufficiencyfemale genital diseases and pregnancy complicationsPathophysiologyStenosisC-Reactive ProteinCA-125 AntigenAortic valve stenosisCardiologybusinessCarbohydrate antigenBiomarkers
researchProduct

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.

2008

Gabriele Nicolini1, Nicola Scichilone2, Andrea Bizzi3, Alberto Papi4, Leonardo M Fabbri51Medical Department, Chiesi Farmaceutici, Parma, Italy; 2University of Palermo, DIMPEFINU, Palermo, Italy; 3Department of Scientific Affairs, Chiesi Farmaceutici, Parma, Italy; 4Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; 5Section of Respiratory Diseases, University of Modena, Modena, ItalyAbstract: Drugs for asthma and other chronic obstructive diseases of the lungs should be preferably delivered by the inhalation route to match therapeutic effects with low systemic exposure. Inhaled drugs are delivered to the lungs via different devices, mainly metered dose inhalers and d…

medicine.medical_specialtyextrafinemoduliteformoterolFormotertolRM1-950ReviewSettore MED/10 - Malattie Dell'Apparato RespiratorioPharmacologybeclomethasoneModuliteExtrafineMedicineBeclomethasone; Extrafine; Formotertol; Modulite;Pharmacology (medical)In patientGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicineAsthmaChemical Health and SafetyInhalationbusiness.industryInhalerTherapeutic effectBeclomethasoneGeneral Medicinemedicine.diseaserespiratory tract diseasesDry powderDrug deliveryasthma therapyTherapeutics. PharmacologyFormoterolbusinessSafety Researchmedicine.drug
researchProduct

Effects of 6 Weeks of Traditional Resistance Training or High Intensity Interval Resistance Training on Body Composition, Aerobic Power and Strength …

2020

Consistent practice of physical activity has well known positive effects on general health

medicine.medical_specialtyhigh intensityHealth Toxicology and MutagenesisPhysical fitnesslcsh:Medicine030204 cardiovascular system & hematologyHigh-Intensity Interval TrainingArticleHigh intensity Physical fitness Recovery time Resistance training Strength03 medical and health sciences0302 clinical medicineWeight lossInternal medicinemental disordersmedicineHumansResting energy expenditurehigh intensity; physical fitness; recovery time; resistance training; strengthMuscle StrengthMuscle SkeletalExerciserecovery timeAerobic capacitymedicine.diagnostic_testbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthResistance training030229 sport sciencesstomatognathic diseasesLean body massCardiologyBody Compositionphysical fitnessComposition (visual arts)medicine.symptomresistance trainingbusinessLipid profilestrengthSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motoriepsychological phenomena and processes
researchProduct